FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel compounds of general formula (I) or to their pharmaceutically acceptable salts or stereoisomers, which possess anti-inflammatory properties. 
(I), where X represents -CO-Y-(R2)n; Y represents (C3-C6)cycloalkyl, (C3-C6)cycloalkenyl or polycycloalkyl, selected from group, which includes adamantly, adamantanmethyl and bicyclooctyl; each R1 is independently selected from hydrogen, (C1-C6)alkyl, fluorine, chlorine, brome or iodine, and n represents integer from 1 to m, where m represents maximal number of substitutions permissible for cyclic group Y.
EFFECT: claimed is preparation, possessing anti-inflammatory action.
8 cl, 2 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIINFLAMMATORY MEDICATIONS | 2004 |
|
RU2365585C2 |
| LIGANDS FOR G-PROTEIN CONJUGATED RECEPTOR | 2005 |
|
RU2454416C2 |
| ANTI-INFLAMMATORY COMPOSITION | 2008 |
|
RU2483730C2 |
| METHOD OF PRODUCING N-(2-HETEROCYCLOALKYL-1-YLETHYL)ADAMANTANE-2-AMINES | 2013 |
|
RU2529201C1 |
| DERIVATIVES OF PYRIMIDINE, METHOD FOR THEIR PREPARING (VARIANTS), PHARMACEUTICAL COMPOSITIONS (VARIANTS) AND INHIBITION METHOD | 2001 |
|
RU2299201C2 |
| CYTOSKELETON-ACTIVE COMPOUNDS, COMPOSITIONS AND USE | 2006 |
|
RU2407745C2 |
| HETEROCYCLIC MEK INHIBITORS AND METHODS OF USING THEREOF | 2006 |
|
RU2414455C2 |
| NEW COMPOUNDS AND COMPOSITIONS FOR CATHEPSIN INHIBITION | 2004 |
|
RU2346943C2 |
| PROCESSES FOR MAKING COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE | 2012 |
|
RU2677292C2 |
| DNA-PK INHIBITORS | 2005 |
|
RU2408596C2 |
